135 related articles for article (PubMed ID: 32285614)
1. Association between cancer-specific adverse event triggers and mortality: A validation study.
Weingart SN; Nelson J; Koethe B; Yaghi O; Dunning S; Feldman A; Kent D; Lipitz-Snyderman A
Cancer Med; 2020 Jun; 9(12):4447-4459. PubMed ID: 32285614
[TBL] [Abstract][Full Text] [Related]
2. Developing a cancer-specific trigger tool to identify treatment-related adverse events using administrative data.
Weingart SN; Nelson J; Koethe B; Yaghi O; Dunning S; Feldman A; Kent DM; Lipitz-Snyderman A
Cancer Med; 2020 Feb; 9(4):1462-1472. PubMed ID: 31899856
[TBL] [Abstract][Full Text] [Related]
3. Trigger Tool-Based Automated Adverse Event Detection in Electronic Health Records: Systematic Review.
Musy SN; Ausserhofer D; Schwendimann R; Rothen HU; Jeitziner MM; Rutjes AW; Simon M
J Med Internet Res; 2018 May; 20(5):e198. PubMed ID: 29848467
[TBL] [Abstract][Full Text] [Related]
4. Performance of a Trigger Tool for Identifying Adverse Events in Oncology.
Lipitz-Snyderman A; Classen D; Pfister D; Killen A; Atoria CL; Fortier E; Epstein AS; Anderson C; Weingart SN
J Oncol Pract; 2017 Mar; 13(3):e223-e230. PubMed ID: 28095173
[TBL] [Abstract][Full Text] [Related]
5. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
[TBL] [Abstract][Full Text] [Related]
6. Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.
Lipitz-Snyderman A; Pfister D; Classen D; Atoria CL; Killen A; Epstein AS; Anderson C; Fortier E; Weingart SN
Cancer; 2017 Dec; 123(23):4728-4736. PubMed ID: 28817180
[TBL] [Abstract][Full Text] [Related]
7. Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors.
Maillet D; Corbaux P; Stelmes JJ; Dalle S; Locatelli-Sanchez M; Perier-Muzet M; Duruisseaux M; Kiakouama-Maleka L; Freyer G; Boespflug A; Péron J
Eur J Cancer; 2020 Jun; 132():61-70. PubMed ID: 32334337
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
9. Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care.
Haukland EC; von Plessen C; Nieder C; Vonen B
BMC Palliat Care; 2020 Jun; 19(1):76. PubMed ID: 32482172
[TBL] [Abstract][Full Text] [Related]
10. Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
Naylor KL; Kim SJ; McArthur E; Garg AX; McCallum MK; Knoll GA
Am J Kidney Dis; 2019 Jun; 73(6):765-776. PubMed ID: 30738630
[TBL] [Abstract][Full Text] [Related]
11. Characteristics associated with the occurrence of adverse events: a retrospective medical record review using the Global Trigger Tool in a fully digitalized tertiary teaching hospital in Korea.
Hwang JI; Chin HJ; Chang YS
J Eval Clin Pract; 2014 Feb; 20(1):27-35. PubMed ID: 23890097
[TBL] [Abstract][Full Text] [Related]
12. Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.
Mendes D; Rigueiro G; Silva RS; Penedones A; Alves C; Sousa G; Batel-Marques F
J Oncol Pharm Pract; 2020 Jan; 26(1):133-140. PubMed ID: 31117914
[TBL] [Abstract][Full Text] [Related]
13. Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method.
Hu Q; Qin Z; Zhan M; Wu B; Chen Z; Xu T
Int J Clin Pharm; 2019 Oct; 41(5):1174-1183. PubMed ID: 31254152
[TBL] [Abstract][Full Text] [Related]
14. Analysing adverse events by time-to-event models: the CLEOPATRA study.
Proctor T; Schumacher M
Pharm Stat; 2016 Jul; 15(4):306-14. PubMed ID: 27313144
[TBL] [Abstract][Full Text] [Related]
15. Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?
Ménard T; Koneswarakantha B; Rolo D; Barmaz Y; Popko L; Bowling R
Drug Saf; 2020 Mar; 43(3):295-296. PubMed ID: 31834590
[No Abstract] [Full Text] [Related]
16. Patient-specific risk factors of adverse drug events in adult inpatients - evidence detected using the Global Trigger Tool method.
Härkänen M; Kervinen M; Ahonen J; Voutilainen A; Turunen H; Vehviläinen-Julkunen K
J Clin Nurs; 2015 Feb; 24(3-4):582-91. PubMed ID: 25393838
[TBL] [Abstract][Full Text] [Related]
17. Risk of treatment-related mortality with sorafenib in patients with cancer.
Zhang XJ; Zhang TY; Yu FF; Wei X; Li YS; Xu F; Wei LX; He J
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6681-6. PubMed ID: 24377588
[TBL] [Abstract][Full Text] [Related]
18. Mitigating risk in Norwegian psychiatric care: Identifying triggers of adverse events through Global Trigger Tool for psychiatric care.
Okkenhaug A; Tritter JQ; Myklebust TÅ; Deilkås ET; Meirik K; Landstad BJ
Int J Risk Saf Med; 2019; 30(4):203-216. PubMed ID: 31561389
[TBL] [Abstract][Full Text] [Related]
19. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
[TBL] [Abstract][Full Text] [Related]
20. Measurement of the incidence of care-associated adverse events at the Department of Pediatrics of a teaching hospital.
Fajreldines A; Schnitzler E; Torres S; Panattieri N; Pellizzari M
Arch Argent Pediatr; 2019 Apr; 117(2):e106-e109. PubMed ID: 30869486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
